1-3 of 3
F. Anthony Greco
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab +/− Bevacizumab for Patients with Previously Treated Follicular Non-Hodgkins Lymphoma: A Randomized Phase II Trial of the Sarah Cannon Research Institute.

John D. Hainsworth, MD, Dana S. Thompson, MD, F. Anthony Greco, MD, Eric Raefsky, MD, Scott Lunin, MD, James Reeves, Jr., MD, Ian W. Flinn, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2749.
https://doi.org/10.1182/blood.V120.21.2749.2749
Published: 2012
Journal Articles

Long-Term Followup of Patients with Follicular Lymphoma (FL) Treated with Two Years of Maintenance Rituximab: Response to Rituximab Retreatment at Progression.

John D. Hainsworth, MD, Christina Meng, David R. Spigel, M.D., Eric L. Raefsky, M.D., John H. Barton, M.D., F. Anthony Greco, M.D.
Journal: Blood
Blood (2006) 108 (11): 4723.
https://doi.org/10.1182/blood.V108.11.4723.4723
Published: 2006
Journal Articles

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma

Clinical Trials & Observations
John D. Hainsworth, Howard A. Burris, III, Lisa H. Morrissey, Sharlene Litchy, Daniel C. Scullin, Jr, James D. Bearden, III, Paul Richards, F. Anthony Greco
Journal: Blood
Blood (2000) 95 (10): 3052–3056.
https://doi.org/10.1182/blood.V95.10.3052
Published: 2000